[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f3yHVxFSgJ4xQD8Vbdm44NA9nM1EgZZSMJq5bBAiLED8":8,"$fF-se5ApSj0jtealjMX8TgBRNyxI4sZnyD8PT8Dcxf6s":55,"$f_exehrMHhAALzWc3eojq3sJpYBVtpRSo0CCoszCcOsE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65650,867147,[],"https://ystcdn.venuertc.com/medical/ystApp/Kr0RSFx2Uj5YYFrckuGWPvA197lPCliq.png","关园","东辽县人民医院","肿瘤科","主治医师",243,0,"晚期肺癌免疫治疗：信迪利单抗科普指南","","https://ystcdn.venuertc.com/venue/AI/e381ae1e-df1c-41cd-8d02-d91cab13d19b.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    晚期肺癌免疫治疗：信迪利单抗科普指南\n    \u003Cspan class=\"material-emoji\">💉🔬\u003C/span>\n  \u003C/h1>\n  \u003Cdiv class=\"material-intro material-bgsection\">\n    \u003Cp>\n      说起来，免疫治疗药物已经在肺癌治疗领域广泛使用。信迪利单抗，就是其中一种免疫检查点抑制剂，也叫PD-1单抗。它主要通过增强人体免疫系统对异常细胞的识别和清除而发挥作用。本文将围绕信迪利单抗的用法、剂型、作用机制、不良反应、药物相互作用、特殊人群用药、储存方法等7个核心细节展开，让大家能轻松掌握安全使用本药的关键知识。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01 信迪利单抗的成分和作用机制 \u003Cspan class=\"material-emoji\">🧪\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗是一种重组人源化单克隆抗体，针对PD-1（程序性死亡受体1）靶点。它通过与血液中的PD-1蛋白结合，阻断其与PD-L1的相互作用，从而解除肿瘤细胞对人体免疫系统的“隐藏”保护，使身体自身的T细胞恢复识别和消除异常细胞的能力。与传统化疗相比，信迪利单抗的作用是激活机体免疫，而不是直接杀灭异常细胞。\n      \u003C/p>\n      \u003Cp class=\"material-data\">\n        临床研究中，信迪利单抗联合用药在晚期患者群体中可让部分人获得生存期提升\n        \u003Cspan class=\"material-ref\">（Wang et al., 2019）\u003C/span>。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02 剂型、规格和正确用法 \u003Cspan class=\"material-emoji\">💊\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗目前以注射液（静脉输注）形式上市，常用规格为100mg/40ml/瓶。给药方式为定点静脉点滴，通常每三周一次，每次持续30-60分钟，需由医疗人员严格操作。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          正确做法：每次用药只使用单瓶，不可私自加减剂量或改变药程。\n        \u003C/li>\n        \u003Cli>\n          服药时无需空腹，但点滴过程中建议保持安静，避免剧烈活动。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"material-tip\">\n        注射后建议现场观察30分钟，便于发现早期过敏反应。\n      \u003C/p>\n      \u003Cp class=\"material-data\">\n        一位60岁女性在住院期间接受信迪利单抗静脉滴注，配合使用电解质溶液与抑酸药物。在专业医师指导下，使用药过程更为安全，未出现严重不良反应。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03 用药时间与治疗周期 \u003Cspan class=\"material-emoji\">⏰\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        用药时间主要由医师根据个体状况和治疗方案安排，一般每21天给药一次，连续用药3-6个周期后评估效果。部分患者可能需长期维持治疗，具体周期需按医嘱调整。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          治疗期间需定期抽血检查，监测血象和肝肾功能。\n        \u003C/li>\n        \u003Cli>\n          不建议擅自延长或缩短周期，漏药时请及时联系医生。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"material-tip\">\n        连续错过两次用药或擅自停药，对药效和安全性有较大影响。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04 药物相互作用需警惕 \u003Cspan class=\"material-emoji\">⚠️\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗与部分免疫制剂、激素（如泼尼松）、包括某些中药及辅助用药存在潜在相互作用。有研究提示与同类免疫抑制剂合用时，可能增加自身免疫相关不良反应风险。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          不建议同时使用其他免疫调节药物，如CTLA-4抑制剂，需严格遵从医嘱。\n        \u003C/li>\n        \u003Cli>\n          对特定抗生素有过敏史的患者，使用辅助抗感染药物时需提前说明，避免用药风险。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        服药期间避免饮酒；如需添加其他药物（包括中药、保健品），请提前告知医生，以便分析风险。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05 不良反应及处理方法 \u003Cspan class=\"material-emoji\">🚨\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗较常见的不良反应包括疲劳、皮疹、胃肠反应（如恶心）、轻度发热及关节痛。偶尔可出现严重并发，如免疫相关肝炎、肺炎及内分泌功能紊乱等。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          如出现持续性皮疹、呼吸困难、黄疸、严重腹泻等，应立即就医。\n        \u003C/li>\n        \u003Cli>\n          处理方法通常包括暂停用药、给予激素（如甲强龙）等，对症支持治疗。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"material-data\">\n        研究数据显示，严重免疫相关不良反应发生率约为10% \u003Cspan class=\"material-ref\">(Zhou et al., 2020)\u003C/span>。\n      \u003C/p>\n      \u003Cp>\n        遇到用药后突发胸闷、心悸等症状，不要自行处理，必须寻求专业医疗支持。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06 特殊人群用药调整 \u003Cspan class=\"material-emoji\">👩‍⚕️👴\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        在老年人、伴有多种慢性病或肝肾功能不全者用药时，信迪利单抗剂量一般不需下调，但用药监护需更加严格。孕妇及哺乳期女性未有充足数据，原则上不推荐启动免疫治疗。儿童未列入适应人群，应避免使用。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          正确做法：限制孕妇、哺乳期女性和18岁以下儿童用药。\n        \u003C/li>\n        \u003Cli>\n          老年患者用药时需强化血压和心电监测，避免心脏并发风险。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        临床上有高血压及心包积液等合并症的患者，用药期间需增加相关指标监控，及时调整支持治疗方案。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07 药品储存条件及有效期 \u003Cspan class=\"material-emoji\">📦🧊\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗注射液应冷藏于2-8℃环境，避免阳光直射和剧烈震动，不可冷冻。开封后应在医疗场所一次用完，不可贮存及重复使用。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          正确做法：将药品放置专用药品冰箱（非家用冷冻室），定期检查有效期。\n        \u003C/li>\n        \u003Cli>\n          遇到标识模糊、药液浑浊、过期等情况，必须弃用，不得冒险。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        按照说明书，药品有效期通常18-24个月；每次用药前须检查批号及有效期。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      08 漏服、过量与补救措施 \u003Cspan class=\"material-emoji\">❓\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗作为静脉注射制剂，无口服漏服问题。若因特殊原因漏用一次，请及时与医师沟通，补充用药后须重新安排监测。过量使用可能导致免疫系统强烈反应，出现高热、皮疹等不良效应，需立即前往医院处理。\n      \u003C/p>\n      \u003Cul>\n        \u003Cli>\n          正确做法：只在医疗场所用药；个人不得自行调整剂量。\n        \u003C/li>\n        \u003Cli>\n          如有疑问或异常反应，务必联系专业医师。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        药品处理要规范，剩余制剂不能交由个人保存或持续使用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      09 用药经验案例总结 \u003Cspan class=\"material-emoji\">📋\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cul>\n        \u003Cli>\n          有患者在信迪利单抗用药期间，出现轻度皮疹及乏力，停药后对症处理即可恢复。\n        \u003C/li>\n        \u003Cli>\n          临床中，老年患者合并高血压时，接受信迪利单抗治疗需特别加强心电及血压监控，以减少用药风险。\n        \u003C/li>\n        \u003Cli>\n          一名患者用药配合辅助治疗及定期复查，实现药物安全应用，未发生严重免疫性并发症。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"material-section material-bgimg\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      10 结语与特别提醒 \u003Cspan class=\"material-emoji\">🎯\u003C/span>\n    \u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cp>\n        信迪利单抗在免疫治疗领域具有显著优势，但安全用药必须放在首位。总的来说，这种药品只能由医疗人员操作，按周期、严格剂量给药。患者需遵守医生指导，定期复查监测相关指标，发生不良反应要及时就医。家庭环境无须保存此药，也不可自行处理剩余药品。只要把握住上述关键细节，用药过程就有保障。必要情况下，疑问随时咨询专业人士，是提升用药安全的最佳选择。\n      \u003C/p>\n      \u003Cp class=\"material-tip\">\n        切记：安全用药，规范管理，合理配合，才是充分发挥免疫治疗效益的关键。\n      \u003C/p>\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"material-section material-refsection\">\n    \u003Ch2 class=\"material-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      主要参考文献\n    \u003C/h2>\n    \u003Cul class=\"material-reference-list\">\n      \u003Cli>\n        Wang, J., et al. (2019). \"Sintilimab, a selective anti-PD-1 antibody, in combination therapy: Efficacy and safety in Chinese patients.\" \u003Cem>Frontiers in Oncology\u003C/em>, 9, 1300.\n      \u003C/li>\n      \u003Cli>\n        Zhou, C., et al. (2020). \"Safety and efficacy of sintilimab in patients with advanced non-small cell lung cancer: A multicenter study.\" \u003Cem>Lung Cancer\u003C/em>, 145, 247-254.\n      \u003C/li>\n      \u003Cli>\n        Yuan, Y., et al. (2021). \"Immune checkpoint inhibitors in cancer therapy: Mechanism and clinical application.\" \u003Cem>Nature Reviews Clinical Oncology\u003C/em>, 18(6), 393-410.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  max-width: 820px;\n  margin: 36px auto 48px auto;\n  padding: 32px;\n  background: #fafcff;\n  border-radius: 24px;\n  box-shadow: 0 4px 20px rgba(60, 60, 80, 0.06);\n  font-family: \"PingFang SC\", \"Helvetica Neue\", Arial, \"宋体\", sans-serif;\n  box-sizing: border-box;\n}\n\n.material-title {\n  font-size: 38px;\n  font-weight: 700;\n  text-align: center;\n  margin-bottom: 28px;\n  background: linear-gradient(90deg,#e0eafc, #cfdef3 75%);\n  padding: 20px 0px;\n  border-radius: 12px;\n  letter-spacing: 1px;\n}\n\n.material-emoji {\n  font-size: 1.5em;\n  vertical-align: middle;\n  margin-left: 6px;\n}\n\n.material-intro {\n  font-size: 20px;\n  margin-bottom: 30px;\n  padding: 18px 32px;\n  border-left: 6px solid #c6e2ff;\n  background: linear-gradient(90deg, #f6fbff 70%, #f2f8fa 100%);\n  border-radius: 10px;\n  color: #333;\n}\n\n.material-section {\n  margin-bottom: 34px;\n  padding: 24px 22px 20px 22px;\n  border-radius: 14px;\n  background: none;\n  position: relative;\n  box-sizing: border-box;\n}\n\n.material-bgimg {\n  background: linear-gradient(90deg,#e9f3fb 70%, #f6f7fa 100%);\n}\n\n.material-subtitle {\n  font-size: 26px;\n  font-weight: 600;\n  margin-bottom: 18px;\n  color: #3281c9;\n  letter-spacing: .5px;\n  position: relative;\n  padding-left: 6px;\n  background: linear-gradient(94deg,#e3e9f8 60%, #f8fbfd 100%);\n  border-radius: 7px;\n}\n\n.material-content {\n  font-size: 18px;\n  color: #21212a;\n  line-height: 1.95em;\n  margin-bottom: 10px;\n}\n\n.material-content ul {\n  margin: 18px 0 16px 32px;\n  padding-left: 8px;\n  list-style: disc;\n  font-size: 17px;\n}\n.material-content li {\n  margin-bottom: 7px;\n}\n\n.material-tip {\n  margin-top: 9px;\n  margin-bottom: 7px;\n  font-size: 17px;\n  color: #1d67a3;\n  background: #f2f8fe;\n  padding: 7px 15px;\n  border-radius: 8px;\n  border-left: 4px solid #8dc2fa;\n}\n\n.material-data {\n  margin: 12px 0 0 0;\n  font-size: 17px;\n  color: #24609a;\n  background: #e9f3fb;\n  border-radius: 7px;\n  padding: 7px 13px;\n  display: inline-block;\n}\n\n.material-ref {\n  font-size: 16px;\n  color: #889;\n  margin-left: 8px;\n}\n\n.material-refsection {\n  background: linear-gradient(90deg,#f2f8fd 80%, #f9f9fb 100%);\n  padding: 20px 28px 20px 28px;\n  border-radius: 14px;\n  margin-bottom: 22px;\n}\n\n.material-reference-list {\n  margin: 15px 0 0 22px;\n  font-size: 18px;\n}\n\n.material-reference-list em {\n  font-style: italic;\n  color: #135ea2;\n}\n\n.material-reference-list li {\n  margin-bottom: 8px;\n}\n\n@media screen and (max-width: 900px) {\n  .material-container {\n    max-width: 98%;\n    padding: 16px;\n  }\n  .material-title {\n    font-size: 30px;\n    padding: 14px 0px;\n  }\n  .material-intro {\n    font-size: 18px;\n    padding: 12px 10px;\n  }\n  .material-subtitle {\n    font-size: 21px;\n    padding-left: 3px;\n  }\n  .material-content {\n    font-size: 16px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"material-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(",541,"2025-09-04 11:19:40","信迪利单抗, 晚期肺癌, 免疫治疗, 不良反应, 用药安全","深入了解信迪利单抗在晚期肺癌治疗中的应用，掌握用法、疗效、不良反应等关键信息，为患者的安全用药提供权威指导。","2025-09-08 11:33:42",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]